Acuitive Technologies earned FDA clearance for the Citrepore bioactive bone filler, the company said Nov. 12.
Four things to know:
1. Citrate is designed for orthopedic surgery and is made with the company's patented Citregen biomaterial.
2. The implant is reabsorbed and replaced by the patient's bone and lets Citrepore guide healing metabolically.
3. Citrepore has more than 80% porosity and is osteoconductive and bioactive.
4. The implant is available in a variety of performed shapes and sizes and can be cut or morselized.